← Back to headlines
Drug Pricing Policy and Eli Lilly Concentration Identified as Key Risks for PPH ETF in 2026
An analysis of the PPH ETF highlights drug pricing policy and the market concentration of pharmaceutical giant Eli Lilly as two significant risks for investors to monitor in 2026.
28 Mar, 11:15 — 28 Mar, 11:15
Sources
Showing 1 of 1 sources
Related Stories
Pathologist Shares Four Simple Rules for Weight Loss
24m ago
British Actress Nikki Sanderson Reveals Abuse Over Pregnancy in Her Forties
28m ago
Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory
33m ago
Azerbaijani Sailor Evacuated from Ship in Constanța Port Due to Medical Emergency
35m ago